on OXURION (EBR:OXUR)
Oxurion Announces Transparency Notification from Atlas Special Opportunities II LLC
On June 18, 2025, Oxurion NV, a biopharmaceutical company, announced that it had received a transparency notification according to Belgian Transparency legislation. On June 16, 2025, Atlas Special Opportunities II, LLC alerted Oxurion that it held 1,548,410 shares as of June 10, 2025. This represents a stake of under 20% due to the sale of voting securities in a total of 8,496,303 shares.
Headquartered in Leuven, Belgium, Oxurion specializes in combining therapeutic innovations with clinical research technologies. This latest development signifies a shift in the ownership structure of the company, as Atlas Special Opportunities II, LLC adjusts its shareholding below the 20% threshold.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news